Hony Capital invests in Biosensors PIPE

The China-focused firm will become the largest shareholder of the Singapore-listed medical device manufacturer, acquiring a 29.47% stake for about S$283.8m.

ByHsiang-Ching Tseng

5 January 2013•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Asia-Pacific East Asia North America Western Europe

Hony Capital invests in Biosensors PIPE

Hony Capital

Asia Alternatives Management

California State Teachers' Retirement System

Goldman Sachs

Goldman Sachs Asset Management

National Council for Social Security Fund of China (NSSF)

Pantheon

Partners Group

Temasek